Logo image of MRX

MAREX GROUP PLC (MRX) Stock Fundamental Analysis

NASDAQ:MRX - Nasdaq - GB00BMT7GT62 - Common Stock - Currency: USD

47.38  +0.28 (+0.59%)

After market: 47.05 -0.33 (-0.7%)

Fundamental Rating

4

Overall MRX gets a fundamental rating of 4 out of 10. We evaluated MRX against 231 industry peers in the Capital Markets industry. Both the profitability and financial health of MRX have multiple concerns. MRX is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MRX was profitable.
In the past year MRX had a positive cash flow from operations.
MRX Yearly Net Income VS EBIT VS OCF VS FCFMRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.24%, MRX is doing worse than 62.77% of the companies in the same industry.
Looking at the Return On Equity, with a value of 30.81%, MRX belongs to the top of the industry, outperforming 96.10% of the companies in the same industry.
Industry RankSector Rank
ROA 1.24%
ROE 30.81%
ROIC N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRX Yearly ROA, ROE, ROICMRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Profit Margin of MRX (9.43%) is worse than 61.90% of its industry peers.
MRX's Profit Margin has improved in the last couple of years.
The Gross Margin of MRX (39.71%) is worse than 65.80% of its industry peers.
In the last couple of years the Gross Margin of MRX has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 9.43%
GM 39.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
MRX Yearly Profit, Operating, Gross MarginsMRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, MRX has more shares outstanding
Compared to 1 year ago, MRX has an improved debt to assets ratio.
MRX Yearly Shares OutstandingMRX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
MRX Yearly Total Debt VS Total AssetsMRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

MRX has an Altman-Z score of 0.27. This is a bad value and indicates that MRX is not financially healthy and even has some risk of bankruptcy.
MRX's Altman-Z score of 0.27 is on the low side compared to the rest of the industry. MRX is outperformed by 70.56% of its industry peers.
The Debt to FCF ratio of MRX is 11.19, which is on the high side as it means it would take MRX, 11.19 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MRX (11.19) is comparable to the rest of the industry.
A Debt/Equity ratio of 10.92 is on the high side and indicates that MRX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 10.92, MRX is doing worse than 89.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 10.92
Debt/FCF 11.19
Altman-Z 0.27
ROIC/WACCN/A
WACCN/A
MRX Yearly LT Debt VS Equity VS FCFMRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.09 indicates that MRX should not have too much problems paying its short term obligations.
MRX has a Current ratio (1.09) which is comparable to the rest of the industry.
A Quick Ratio of 1.09 indicates that MRX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.09, MRX perfoms like the industry average, outperforming 51.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
MRX Yearly Current Assets VS Current LiabilitesMRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5B 10B 15B 20B

More info and screens

8

3. Growth

3.1 Past

MRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.41%, which is quite impressive.
The Earnings Per Share has been growing by 50.49% on average over the past years. This is a very strong growth
MRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.81%.
MRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.98% yearly.
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%

3.2 Future

Based on estimates for the next years, MRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.31% on average per year.
The Revenue is expected to grow by 10.23% on average over the next years. This is quite good.
EPS Next Y14.9%
EPS Next 2Y13.06%
EPS Next 3Y12.31%
EPS Next 5YN/A
Revenue Next Year12.91%
Revenue Next 2Y10.85%
Revenue Next 3Y10.23%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MRX Yearly Revenue VS EstimatesMRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
MRX Yearly EPS VS EstimatesMRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 1 2 3 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.90, the valuation of MRX can be described as very reasonable.
Based on the Price/Earnings ratio, MRX is valued a bit cheaper than the industry average as 62.34% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of MRX to the average of the S&P500 Index (24.21), we can say MRX is valued rather cheaply.
With a Price/Forward Earnings ratio of 13.72, MRX is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as MRX.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, MRX is valued a bit cheaper.
Industry RankSector Rank
PE 11.9
Fwd PE 13.72
MRX Price Earnings VS Forward Price EarningsMRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRX indicates a rather cheap valuation: MRX is cheaper than 87.88% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.95
EV/EBITDA N/A
MRX Per share dataMRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRX's earnings are expected to grow with 12.31% in the coming years.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y13.06%
EPS Next 3Y12.31%

More info and screens

1

5. Dividend

5.1 Amount

MRX has a Yearly Dividend Yield of 1.28%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 8.50, MRX is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, MRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

MRX has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MRX Yearly Dividends per shareMRX Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y13.06%
EPS Next 3Y12.31%
MRX Yearly Income VS Free CF VS DividendMRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

MAREX GROUP PLC

NASDAQ:MRX (5/9/2025, 8:09:53 PM)

After market: 47.05 -0.33 (-0.7%)

47.38

+0.28 (+0.59%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-06 2025-03-06/bmo
Earnings (Next)05-15 2025-05-15
Inst Owners44.65%
Inst Owner Change0%
Ins Owners5.89%
Ins Owner ChangeN/A
Market Cap3.37B
Analysts81.67
Price Target45.14 (-4.73%)
Short Float %1.87%
Short Ratio0.71
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2025-03-17 (0.14)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.61%
Min EPS beat(2)11.13%
Max EPS beat(2)18.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.52%
Min Revenue beat(2)2.3%
Max Revenue beat(2)8.73%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.92%
PT rev (3m)17.61%
EPS NQ rev (1m)16.45%
EPS NQ rev (3m)22.32%
EPS NY rev (1m)6.56%
EPS NY rev (3m)12.54%
Revenue NQ rev (1m)6.02%
Revenue NQ rev (3m)12.98%
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)6.47%
Valuation
Industry RankSector Rank
PE 11.9
Fwd PE 13.72
P/S 1.06
P/FCF 2.95
P/OCF 2.9
P/B 3.45
P/tB 4.54
EV/EBITDA N/A
EPS(TTM)3.98
EY8.4%
EPS(NY)3.45
Fwd EY7.29%
FCF(TTM)16.06
FCFY33.89%
OCF(TTM)16.33
OCFY34.48%
SpS44.8
BVpS13.71
TBVpS10.44
PEG (NY)0.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.24%
ROE 30.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 9.43%
GM 39.71%
FCFM 35.84%
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 10.92
Debt/FCF 11.19
Debt/EBITDA N/A
Cap/Depr 69.1%
Cap/Sales 0.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 379.93%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 0.27
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)64.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.86%
Cap/Sales(5y)N/A
Profit Quality(3y)453.15%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
EPS Next Y14.9%
EPS Next 2Y13.06%
EPS Next 3Y12.31%
EPS Next 5YN/A
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%
Revenue Next Year12.91%
Revenue Next 2Y10.85%
Revenue Next 3Y10.23%
Revenue Next 5YN/A
EBIT growth 1Y-18.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.29%
EBIT Next 3Y14.38%
EBIT Next 5YN/A
FCF growth 1Y58.2%
FCF growth 3Y35.13%
FCF growth 5YN/A
OCF growth 1Y58.3%
OCF growth 3Y35.2%
OCF growth 5YN/A